DAVITA INC. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
DAVITA INC. (DVA) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $3.84 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2021-10-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2022-02-11
- DAVITA INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2020-03-31 was $2.40M, a 58.01% increase year-over-year.
- DAVITA INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2019-12-31 was $4.05M, a 15.19% decline year-over-year.
- DAVITA INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2019-09-30 was $5.23M, a 7.85% decline year-over-year.
- DAVITA INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2019-06-30 was $590.00K.
- DAVITA INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2019 was $11.38M, a 16.17% decline from fiscal 2018.
- DAVITA INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2018 was $13.58M, a 36.11% decline from fiscal 2017.
- DAVITA INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2017 was $21.25M, a 9.73% decline from fiscal 2016.
- DAVITA INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2016 was $23.54M.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month |
|---|---|---|---|---|
| 2020-09-30 | $3.84M 10-Q · filed 2021-10-28 | |||
| 2020-03-31 | $2.40M 10-Q · filed 2021-04-29 | $6.45M derived: sum of 2 quarters · filed 2022-02-11 | $11.67M derived: sum of 3 quarters · filed 2022-02-11 | $12.26M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $9.28M derived: sum of 2 quarters · filed 2022-02-11 | $9.87M derived: sum of 3 quarters · filed 2022-02-11 | $11.38M 10-K · filed 2022-02-11 |
| 2019-09-30 | $5.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $5.82M derived: sum of 2 quarters · filed 2020-10-29 | $7.33M 10-Q · filed 2020-10-29 | $12.11M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $590.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.11M 10-Q · filed 2020-07-30 | $6.88M derived: sum of 3 quarters · filed 2021-02-12 | $12.55M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $1.52M 10-Q · filed 2020-05-05 | $6.29M derived: sum of 2 quarters · filed 2021-02-12 | $11.96M derived: sum of 3 quarters · filed 2021-02-12 | |
| 2018-12-31 | $4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $10.45M derived: sum of 2 quarters · filed 2021-02-12 | $13.58M 10-K · filed 2021-02-12 | |
| 2018-09-30 | $5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $8.80M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $3.13M 10-Q · filed 2019-08-02 | |||
| 2017-12-31 | $21.25M 10-K · filed 2020-02-21 | |||
| 2016-12-31 | $23.54M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |